Lung-specific loss of a3 laminin worsens bleomycin-induced pulmonary fibrosis

American Journal of Respiratory Cell and Molecular Biology

Volumn 52, Issue 4, 2015, Pages 503-512

  Morales Nebreda, Luisa I ^a   Rogel, Micah R ^a   Eisenberg, Jessica L ^a,b   Hamill, Kevin J ^a,c   Soberanes, Saul ^a   Nigdelioglu, Recep ^a   Chi, Monica ^a   Cho, Takugo ^a   Radigan, Kathryn A ^a   Ridge, Karen M ^a   Misharin, Alexander V ^a   Woychek, Alex ^d   Hopkinson, Susan ^a,d   Perlman, Harris ^a   Mutlu, Gokhan M ^a   Pardo, Annie ^e   Selman, Moises ^f   Jones, Jonathan C R ^a,d   Scott Budinger, G R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

^d WASHINGTON STATE UNIVERSITY   (United States)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^f INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

Author keywords

Development; Laminin; Matrix; Pulmonary fibrosis

Indexed keywords

ALPHA3 LAMININ; BLEOMYCIN; COLLAGEN TYPE 4; CONNECTIVE TISSUE GROWTH FACTOR; CRE RECOMBINASE; LAMININ; PLASMINOGEN ACTIVATOR INHIBITOR 1; RNA; SURFACTANT PROTEIN C; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; LAMININ ALPHA 3;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; CONTROLLED STUDY; DENSITOMETRY; DISEASE SEVERITY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; GENETIC RECOMBINATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; INFLAMMATION; INFLAMMATORY CELL; LIMIT OF DETECTION; LUNG ALVEOLUS EPITHELIUM; LUNG COMPLIANCE; LUNG MECHANICS; MORTALITY; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN DEPLETION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TOTAL LUNG CAPACITY; ANIMAL; CHEMICALLY INDUCED; LUNG; LUNG ALVEOLUS; LUNG FIBROSIS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ADENOVIRIDAE; MUS;

ANIMALS; BLEOMYCIN; HUMANS; LAMININ; LUNG; MICE, TRANSGENIC; PULMONARY ALVEOLI; PULMONARY FIBROSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84929657150     PISSN: 10441549     EISSN: 15354989     Source Type: Journal    
DOI: 10.1165/rcmb.2014-0057OC     Document Type: Article

References (39)

1. Budinger GR, Sznajder JI. The alveolar-epithelial barrier: a target for potential therapy. Clin Chest Med 2006;27:655-669. (abstract ix.).
2. Selman M, King TE Jr, Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-151.
3. King TE Jr, Pardo A, Selman M. Idiopathic pulmonary fibrosis. Lancet 2011;378:1949-1961.
4. Booth AJ, Hadley R, Cornett AM, Dreffs AA, Matthes SA, Tsui JL, Weiss K, Horowitz JC, Fiore VF, Barker TH, et al. Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am J Respir Crit Care Med 2012;186:866-876.
5. Miner JH. Laminins and their roles in mammals. Microsc Res Tech 2008; 71:349-356.
6. Pierce RA, Griffin GL, Susan Mudd M, Moxley MA, Longmore WJ, Sanes JR, Miner JH, Senior RM. Expression of laminin alpha 3, alpha 4, and alpha 5 chains by alveolar epithelial cells and fibroblasts. Am J Respir Cell Mol Biol 1998;19:237-244.
7. Schuger L, O'Shea S, Rheinheimer J, Varani J. Laminin in lung development: effects of anti-laminin antibody in murine lung morphogenesis. Dev Biol 1990;137:26-32.
8. Willem M, Miosge N, Halfter W, Smyth N, Jannetti I, Burghart E, Timpl R, Mayer U. Specific ablation of the nidogen-binding site in the laminin g1 chain interferes with kidney and lung development. Development 2002;129:2711-2722.
9. Laimer M, Lanschuetzer CM, Diem A, Bauer JW. Herlitz junctional epidermolysis bullosa. Dermatol Clin 2010;28:55-60.
10. Jones JC, Dehart GW, Gonzales M, Goldfinger LE. Laminins: an overview. Microsc Res Tech 2000;51:211-213.
11. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011;183:788-824.
12. Urich D, Eisenberg JL, Hamill KJ, Takawira D, Chiarella SE, Soberanes S, Gonzalez A, Koentgen F, Manghi T, Hopkinson SB, et al. Lungspecific loss of the laminin a3 subunit confers resistance to mechanical injury. J Cell Sci 2011;124:2927-2937.
13. Okubo T, Knoepfler PS, Eisenman RN, Hogan BLM. Nmyc plays an essential role during lung development as a dosage-sensitive regulator of progenitor cell proliferation and differentiation. Development 2005;132:1363-1374.
14. Urich D, Soberanes S, Burgess Z, Chiarella SE, Ghio AJ, Ridge KM, Kamp DW, Chandel NS, Mutlu GM, Budinger GR. Proapoptotic noxa is required for particulate matter-induced cell death and lung inflammation. FASEB J 2009;23:2055-2064.
15. Feng X-H, Filvaroff EH, Derynck R. Transforming growth factor-b (TGF-b)-induced down-regulation of cyclin A expression requires a functional TGF-b receptor complex. J Biol Chem 1995;270:24237-24245.
16. Bonniaud P, Kolb M, Galt T, Robertson J, Robbins C, Stampfli M, Lavery C, Margetts PJ, Roberts AB, Gauldie J. Smad3 null mice develop airspace enlargement and are resistant to TGFbeta- mediated pulmonary fibrosis. J Immunol 2004;173:2099-2108.
17. Budinger GR, Mutlu GM, Eisenbart J, Fuller AC, Bellmeyer AA, Baker CM, Wilson M, Ridge K, Barrett TA, Lee VY, et al. Proapoptotic bid is required for pulmonary fibrosis. Proc Natl Acad Sci USA 2006;103:4604-4609.
18. Budinger GR, Tso M, McClintock DS, Dean DA, Sznajder JI, Chandel NS. Hyperoxia induced apoptosis does not require mitochondrial reactive oxygen species and is regulated by bcl-2 proteins. J Biol Chem 2002;277:15654-15660.
19. Mutlu GM, Budinger GRS, Wu M, Lam AP, Zirk A, Rivera S, Urich D, Chiarella SE, Go LHT, Ghosh AK, et al. Proteasomal inhibition after injury prevents fibrosis by modulating TGF-b1 signalling. Thorax 2012;67:139-146.
20. Anonymous. Scireq science: measurements. 2010 [cited 2010 September 1, 2010]. Available from: http://www.scireq.com/science/measurements/.
21. Price AP, England KA, Matson AM, Blazar BR, Panoskaltsis-Mortari A. Development of a decellularized lung bioreactor systemfor bioengineering the lung: the matrix reloaded. Tissue Eng Part A 2010;16:2581-2591.
22. Klatte DH, Kurpakus MA, Grelling KA, Jones JC. Immunochemical characterization of three components of the hemidesmosome and their expression in cultured epithelial cells. J Cell Biol 1989;109:3377-3390.
23. Schmittgen TD, Livak KJ. Analyzing real-time pcr data by the comparative C(t) method. Nat Protoc 2008;3:1101-1108.
24. Misharin AV, Morales-Nebreda L, Mutlu GM, Budinger GRS, Perlman H. Flow cytometric analysis of the macrophages and dendritic cell subsets in the mouse lung. Am J Respir Cell Mol Biol 2013;49:503-510.
25. Ryan MC, Lee K, Miyashita Y, Carter WG. Targeted disruption of the lama3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol 1999;145:1309-1324.
26. Zhou L, Lim L, Costa RH, Whitsett JA. Thyroid transcription factor-1, hepatocyte nuclear factor-3beta, surfactant protein B, C, and Clara cell secretory protein in developing mouse lung. J Histochem Cytochem 1996;44:1183-1193.
27. Sheppard D. Transforming growth factor {beta}: a central modulator of pulmonary and airway inflammation and fibrosis. Proc Am Thorac Soc 2006;3:413-417.
28. Jones JC, Lane K, Hopkinson SB, Lecuona E, Geiger RC, Dean DA, Correa-Meyer E, Gonzales M, Campbell K, Sznajder JI, et al. Laminin-6 assembles into multimolecular fibrillar complexes with perlecan and participates in mechanical-signal transduction via a dystroglycan-dependent, integrin-independent mechanism. J Cell Sci 2005;118:2557-2566.
29. Nguyen NM, Senior RM. Laminin isoforms and lung development: all isoforms are not equal. Dev Biol 2006;294:271-279.
30. Hamill KJ, Kligys K, Hopkinson SB, Jones JC. Laminin deposition in the extracellular matrix: a complex picture emerges. J Cell Sci 2009;122:4409-4417.
31. Sehgal BU, DeBiase PJ, Matzno S, Chew TL, Claiborne JN, Hopkinson SB, Russell A, Marinkovich MP, Jones JC. Integrin beta4 regulates migratory behavior of keratinocytes by determining laminin-332 organization. J Biol Chem 2006;281:35487-35498.
32. Goldfinger LE, Hopkinson SB, deHart GW, Collawn S, Couchman JR, Jones JC. The alpha3 laminin subunit, alpha6beta4 and alpha3beta1 integrin coordinately regulate wound healing in cultured epithelial cells and in the skin. J Cell Sci 1999;112:2615-2629.
33. Chapman HA, Li X, Alexander JP, Brumwell A, Lorizio W, Tan K, Sonnenberg A, Wei Y, Vu TH. Integrin a6b4 identifies an adult distal lung epithelial population with regenerative potential in mice. J Clin Invest 2011;121:2855-2862.
34. Martin GR, Timpl R. Laminin and other basement membrane components. Annu Rev Cell Biol 1987;3:57-85.
35. Matute-Bello G, Frevert CW, Martin TR. Animal models of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2008;295:L379-L399.
36. Munger JS, Huang X, Kawakatsu H, Griffiths MJ, Dalton SL, Wu J, Pittet JF, Kaminski N, Garat C, Matthay MA, et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: a mechanism for regulating pulmonary inflammation and fibrosis. Cell 1999;96:319-328.
37. Parker MW, Rossi D, Peterson M, Smith K, Sikström K, White ES, Connett JE, Henke CA, Larsson O, Bitterman PB. Fibrotic extracellular matrix activates a profibrotic positive feedback loop. J Clin Invest 2014;124:1622-1635.
38. Has C, SpartàG, Kiritsi D, Weibel L, Moeller A, Vega-Warner V, Waters A, He Y, Anikster Y, Esser P, et al. Integrin a3 mutations with kidney, lung, and skin disease. N Engl J Med 2012;366:1508-1514.
39. Kim Y, Kugler MC, Wei Y, Kim KK, Li X, Brumwell AN, Chapman HA. Integrin alpha3beta1-dependent beta-catenin phosphorylation links epithelial Smad signaling to cell contacts. J Cell Biol 2009;184:309-322.